Collaborations (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and contract liabilities for the three months ended March 31, 2024 (in thousands):

	Balance at December 31, 2023		Additions		Deductions			Balance at March 31, 2024
Accounts receivable and contract assets:
Billed receivables - Sanofi	$	15,000	$	3,762	$	(18,762	)	$	—
Unbilled receivables - Sanofi		3,762		2,030		(3,762	)		2,030
Total accounts receivable and contract assets	$	18,762	$	5,792	$	(22,524	)	$	2,030
Contract liabilities:
Deferred revenue - Sanofi	$	54,651	$	2,030	$	(10,287	)	$	46,394
Total contract liabilities	$	54,651	$	2,030	$	(10,287	)	$	46,394